Enanta Pharmaceuticals, Inc: Respiratory Syncytial Virus Infections trials

The registry lists 14 Respiratory Syncytial Virus Infections studies with Enanta Pharmaceuticals, Inc as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 9Phase 2 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial VirusRecruitingNCT07482657Phase 2
• A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge ModelCompletedNCT06170242Phase 2Results posted
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.CompletedNCT05568706Phase 2Results posted
• Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractTerminatedNCT04633187Phase 2Results posted
• A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge ModelCompletedNCT03691623Phase 2Results posted
• A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy ParticipantsCompletedNCT06917508Phase 1
• A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.CompletedNCT06847464Phase 1
• A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy AdultsCompletedNCT06601192Phase 1
• A Study of EDP-323 in Healthy SubjectsCompletedNCT05587478Phase 1
• Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy SubjectsCompletedNCT04871724Phase 1
• Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsCompletedNCT04498741Phase 1
• Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy SubjectsCompletedNCT03755778Phase 1
• Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult SubjectsCompletedNCT03750383Phase 1
• A Study of EDP-938 in Healthy SubjectsCompletedNCT03384823Phase 1